Induction of Labor (IOL) Using Cervical Double-balloon (Cook Catheter) in Outpatient Versus Inpatient Setting (COOK Study): a Multicentre, Randomised Controlled Trial.
Trial Snapshot
- Phase
- Not Applicable
- Status
- Terminated
- Sponsor
- Enrollment
- 358
- Locations
- 4
- Primary Endpoint
- Fetal wellbeing
Study Overview
Brief Summary
Why was this study done? About 20-30% of pregnancies involve labor being started artificially, known as induction. One way to do this is with a balloon catheter placed in the cervix, which helps prepare the body for labor. This mechanical method works just as well as using medication but may be safer for the baby, as it reduces the chances of the womb contracting too much (which can cause stress to the baby). Because it's safe and simple, this method could possibly be done at home instead of in the hospital.
What was the aim of the study? The researchers wanted to compare how safe and effective this balloon method is when used at home (outpatient) versus in the hospital (inpatient). They also wanted to know how satisfied women were with each approach.
How was the study done? The study took place at four hospitals in Belgium between 2017 and 2023. It included women with healthy low risk pregnancies who were scheduled for induction for non-urgent reasons, such as being past their due date, having a large baby, or by personal choice after 38 weeks of pregnancy.
The women were randomly placed into two groups:
Outpatient setting: going home after balloon placement.
Inpatient setting: staying in the hospital after balloon placement<
The main thing researchers measured was whether the baby's heart rate pattern (checked by CTG monitoring) was abnormal after 12 hours. They also looked at how the baby was born (vaginal birth or C-section), how long labor took, whether additional medicine was needed, pain management, and how satisfied the mothers were with the process.
Detailed Description
Study Design and Approval
This was a randomised controlled trial - a scientific study designed to compare two groups as fairly as possible. It took place in four hospitals in Belgium:
Ziekenhuis Oost-Limburg (ZOL), Genk
AZ Sint-Lucas, Brugge
Jessa Ziekenhuis, Hasselt
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •women >18 years of age with singleton pregnancies, cephalic presentation and a unfavourable cervix requiring priming (Bishop Score ≤ 6) that needed an IOL for low risk indications: post-term, macrosomia, patient's preference (> 38 0/7 weeks of gestational age).
Exclusion Criteria
- •: multiple pregnancies, preterm premature rupture of membranes (pPROM), foetal growth restriction (FGR), placenta-accreta spectrum (PAS), previous C-Section(s), non-cephalic presentation, gestational diabetes, hypertensive disorders of pregnancy, living at >60 minutes from the hospital, any other maternal or foetal morbidity, any other contraindication to vaginal birth.
Arms & Interventions
Inpatient
Patient in this arm were randomized to stay in the hospital during cervical balloon ripening
Intervention: cervical balloon catheter (Device)
Outpatient
Patients in this arm were randomized to ambulant home setting during cervical ripening
Intervention: cervical balloon catheter (Device)
Outcomes
Primary Outcomes
Fetal wellbeing
Time Frame: 12 hours
The primary outcome was foetal wellbeing assessed by cardiotocography (CTG) immediately after balloon insertion and balloon removal (12 hours after insertion). The CTG could be normal or not normal. The CTG was reported as not normal in case of a baseline rise, decelerations (even if they were not repeated decelerations) or decreased variability. The second CTG assessment was performed earlier in case of vaginal bleeding, fluid loss, onset of regular painful contractions, balloon expulsion or in any other case judged clinically relevant by the obstetrician
Secondary Outcomes
No secondary outcomes reported
